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Idiopathic Pulmonary Hypertension (IPAH) is characterized by elevated pulmonary arterial
pressure in the absence of an identifiable underlying cause. The condition is usually
relentlessly progressive with a short survival in the absence of treatment.1 We describe a
patient of IPAH in whom the pulmonary artery pressures significantly abated with com-
plete disappearance of symptoms, following spontaneous development of a pulmonary
arterio-venous malformation (PAVM).
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
Pulmonary artery hypertension (PAH) is a disease that carries
a poor prognosis.1 While specific therapy targeting the pul-
monary vasculature does improve symptoms and prolong life,
the condition progresses regardless of treatment. We report a
case of a young woman with PAH who had complete remis-
sion of her symptoms with improvement in her pulmonaryonary Medicine, Owaisi H
agh), Hyderabad 500058,
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ociety of India. All rightsartery pressures following spontaneous development of a
pulmonary artery venous fistula.2. Case presentation
A 26 year old housewife was referred to our centre for evalu-
ation. Five years earlier she had developed progressive dys-
pnea on exertion with one episode of pre-syncope whileospital and Research Centre/Deccan College of Medical Sciences,
India. Tel.: þ91 9848251708 (mobile), þ91 9848051708 (mobile).
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taken any anorectic drugs. There was no history of similar
disease in her family. Physical examination revealed no
visible cutaneous telangectasiae. She had undergone a
comprehensive workup which included spirometry, HIV
serology and collagen vascular profile, all of which proved
non-diagnostic.
At the time of initial workup, she underwent a chest X-ray
(Fig. 1b) and chest CT-pulmonary angiography [CTPA] (Fig. 1b),
both of which revealed dilatation of the pulmonary vascula-
ture as also the right heart chambers. ECG showed right-axis
deviation of QRS complex with right ventricular hypertro-
phy; Echocardiogram showed dilated right atrium, right
ventricle and pulmonary arteries, and mild tricuspid regurgi-
tation. The estimated pulmonary artery systolic pressure
(PASP) based on tricuspid regurgitation jet velocity was
80 mmHg. There were no evidence of any cardiac shunt le-
sions and biventricular function was normal. Right heart
catheterization done at that time confirmed pulmonary artery
hypertension with a negative vasodilator challenge.
Following this the patient was commenced on oral sil-
denafil citrate (25 mg thrice daily). She was advised against
becoming pregnant.
A year later (about4 years before presentation to our
institute), she had four episodes ofmild hemoptysis, following
which she was re-investigated. All investigations showed re-
sults that were more or less identical to those before, except
that the echocardiogram now showed paradoxical septal mo-
tion with TR, and the estimated PASP had risen to 80 mmHg.
Without any other apparent etiology, the hemoptysis was
ascribed to the PAH, and the dose of sildenafil was increased
to 50 mg thrice daily.
Over the next couple of years, the patient conceived twice.
Echocardiograms that were done as part of her antenatal
workup showed severe PAH, with PASPs ranging from 80 to
85 mmHg; on both occasions, she was persuaded to terminate
her pregnancy.
Subsequently, her dyspnea began to improve, and about a
year and a half before her presentation to us, her PASP had
decreased to 65 mmHg on echocardiography. About a year
before her first visit to our institute, the PASP had further
declined to 46 mmHg, and the echocardiogram now revealedFig. 1 e (a) Postero-anterior chest film of the patient (done at ini
our institute), showing dilated pulmonary vasculature with per
the same period) showing prominent main, left and right pulmonly mild dilatation of right heart chambers. Commensu-
rately, her ECG showed decrease in right axis and right ven-
tricular forces.
A re-evaluation once again failed to reveal an underlying
cause. The patient conceived once again (for the third time),
but this time spontaneously aborted at 6 weeks' gestation.
At this time she presented at our institute. She was less
symptomatic than before. We noticed a small opacity in the
left mid zone in one of herrecent chest radiographs (Fig. 2b),
which had possibly escaped detection earlier (Fig. 2a-open
arrow).
A repeat CTPA revealed a large arteriovenous malforma-
tion measuring 33  36  30 mm in the left lower lobe (Fig. 3).
The study was negative for pulmonary thromboembolism.
Echocardiography showed a normal RA and RV size and no
PAH. The patient was reoffered a repeat right heart catheter-
ization, but refused.3. Discussion
The clinical course in this patient is remarkable. IPAH is a
disease which inexorably progresses, and seldom if ever,
remits.2 However after progressively worsening for a few
years, her symptoms steadily abated, with a commensurate
improvement on serial echocardiograms. The high PASPs
during the initial course of her illness, as indeed their later
fall were confirmed by different observers on each occasion.
The decrease in right ventricular forces on ECG also supports
this. Unfortunately, the patient refused right heart
catheterization.
We believe that the fall in the PA pressures of this magni-
tude is due to the development of a PAVM, resulting in a low-
resistance circuit. Sildenafil treatment generally improves
symptoms, but does not decrease pulmonary artery pressures
to such an extent.3
Hemoptysis is a recognized finding in PAH. It is conceivable
that the episodes of hemoptysis could have resulted from tiny
sub-radiological PAVMs.4 We believe that the enlarging high-
flow, low-resistance PAVM could have significantly contrib-
uted to the improved hemodynamics in this patient, and
limited the progression of PAH.tial workup of the patient, five years before presentation to
ipheral pruning. (b) CT pulmonary angiogram (done during
onary arteries and dilated right heart chambers.
Fig. 2 e (a) Chest radiograph done about a year and a half before presentation shows a lobulated opacity in the left mid zone
(open arrow). This had possibly escaped detection of the observer at this time. (b) Chest radiograph done at presentation to
our institute. The lobulated opacity in the left mid zone is seen to be much more prominent than in the film (Fig. 2a) done a
year and a half ago.
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been described in dogs with Angiostrongylus vasorum infec-
tion.5 Sperling et al6 described two cases of multiparous
womenwith PAHwho subsequently developed PAVMs: in one
of these, the mean PA pressures decreased after the PAVM
developed. Minai et al described a woman with hereditary
haemorrhagic telangiectasia (HHT) and PAH,7 in whom a
decrease in PA mean pressure and stabilization of the clinical
course occurred parri passu with the development of PAVMs,
while on therapy with pulmonary vasodilators.
Small arteriovenous fistulae can exist at the apices of
segmental subdivisions in proximity to the visceralFig. 3 e A CT-Pulmonary angiogram (CTPA) at presentation
shows a large irregular lobulated aneurismal dilatation
measuring 33 £ 36 £ 30 mm in the left lower lobe fed by
the left inferior pulmonary artery and draining into the left
inferior pulmonary vein. This study, like the initial CTPA,
was negative for any pulmonary thromboembolic process.pleuradprecisely where clinically significant PAVMs are
prone to occur.8 These could enhance in their size secondary
to increasing mean PA pressures.9 Rupture of hypoplastic
vascular septa under increased pressure conceivably
contribute to an increase in the size of AV malformations.6
Solitary or multiple PAVMs can occur as part of Hereditary
Haemorrhagic Telangectasia (HHT), where they are indistin-
guishable from idiopathic PAVMs (idiopathic PAVMs tend to
be solitary while those in HHT are generally multiple and
bilateral).10 The association of PAVMs with PAH can be on
account of geneticmutations than predispose to both diseases
or where the PAH may promote enlargement of the PAVM. In
one study HHT occurredwithin 4 of 104 families with PAH.11 It
is relevant that mutations at ENG, ACVRL1 are associated with
both HHT and familial PAH; mutations of another TGF super-
family member gene (BMPR2) are associated with familial
PAH.12 Our patient showed no clinical features of HHT. Un-
fortunately facilities for genetic studies are currently not
available at our centre.
All patients with significant PAVMs should normally be
considered for endovascular closure or surgical removal. This
may be critically important for an impending pregnancy
(given that no PAH exists to contraindicate pregnancy). During
the latter half of pregnancy, PAVMs can bleed or even rupture
with disastrous consequences. However in the context of PAH,
therapeutic obliteration of the low resistance channel affor-
ded by the PAVM could also be catastrophic. Indeed, emboli-
zation or resection of a PAVM has resulted in fatality.12
This patient was stringently advised against becoming
pregnant. It was considered prudent to continue the sildenafil.
A repeat right heart catheterization and genetic studies would
have been ideal.4. Conclusion
PAVMs can rarely occur in association with PAH. Tiny areas of
weakness in the pulmonary vasculature can enlarge in size
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 5 3 5e5 3 8538secondary to the increased pulmonary artery pressure. In rare
cases such as this, the PAVMmayhalt or delay the progression
of an otherwise unremitting condition.Conflicts of interest
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